x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The BioWorld Insider Podcast

One-on-one with medical innovators: Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma"s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collective

science life sciences

All Episodes

24:00

Supply Chain Geeky: Managing through the challenges...

The BioWorld Insider Podcast ·

2021/12/09

Paul Testa, executive vice president for operations and supply chain at Tokyo-based Kyowa Kirin, on the dramatic importance of continuity, reliability of supply, business process and automation. Hosted on Acast. See acast.com/privacy for more information.

en

28:54

Regulatory Gemish: COVID-19’s big impacts on the FDA...

The BioWorld Insider Podcast ·

2021/12/09

Peter Pitts, president of the Center for Medicine in the Public Interest, on how government regulation seems like a slow but in actuality moves more quickly than understood. Hosted on Acast. See acast.com/privacy for more information.

en

16:39

Reality check: How did industry develop COVID-19...

The BioWorld Insider Podcast ·

2021/10/26

BioWorld Regulatory Editor Mari Serebrov puts the pandemic and the science into perspective. Hosted on Acast. See acast.com/privacy for more information.

en

28:16

Merck’s new COVID-19 pill will save lives, but at...

The BioWorld Insider Podcast ·

2021/10/18

Joseph Allen, executive director of the Bayh-Dole Coalition, explains how molnupiravir, from Ridgeback Biotherapeutics, and partner Merck & Co. Inc., may have never had a chance to move out of the university onto pharmacy shelves without the government’s support. Hosted on Acast. See acast.com/privacy for more information.

en

18:01

Newly approved cervical cancer drug Tivdak gives...

The BioWorld Insider Podcast ·

2021/09/24

The approval of antibody-drug conjugate Tivdak (tisotumab vedotin) for treating cervical cancer and the future of Genmab A/S are the subjects with the company's president and CEO, Jan van de Winkel. Hosted on Acast. See acast.com/privacy for more information.

en

26:08

DNA vaccines: a better path to taming the pandemic?

The BioWorld Insider Podcast ·

2021/09/17

An in-depth conversation with Lucio Rovati, CEO and chief scientific officer of Italy’s Rottapharm Biotech as they tackle the new world of DNA vaccines. Hosted on Acast. See acast.com/privacy for more information.

en

24:50

Rising to the COVID-19 challenge, clinical trials evolve

The BioWorld Insider Podcast ·

2021/09/02

Laurie Halloran, president and CEO of Boston-based Halloran Consulting, shares her thoughts on the impact of COVID-19 on clinical trials.

en

31:28

A ‘Revolution’ in drugging the undruggable hits a...

The BioWorld Insider Podcast ·

2021/08/20

Mark Goldsmith, Revolution Medicines Inc. president, CEO and chairman, talks about grappling with RAS mutations. Hosted on Acast. See acast.com/privacy for more information.

en

34:05

As dementia cases grow, biomarkers and new therapies...

The BioWorld Insider Podcast ·

2021/07/30

Howard Fillit, founding executive director and chief science officer at the Alzheimer’s Drug Discovery Foundation, shares his insights on the impact of financial investments driving these therapies.

en

14:22

As biopharma deals keep pace, M&A volumes languish

The BioWorld Insider Podcast ·

2021/07/09

Biopharma deal-making activity, a closely watched marker of industry health, was alive and well in the second quarter. BioWorld Senior Analyst Karen Carey sifts through the numbers. Hosted on Acast. See acast.com/privacy for more information.

en

12:33

Iteos brings Glaxosmithkline a third...

The BioWorld Insider Podcast ·

2021/06/16

Michel Detheux, president and CEO of Iteos Therapeutics Inc., discusses what his company brings GSK in a massive new deal. Hosted on Acast. See acast.com/privacy for more information.

en

09:17

Finally, a new medicine for Alzheimer’s disease

The BioWorld Insider Podcast ·

2021/06/10

Biogen’s vice president of global and U.S. medical affairs for Alzheimer’s disease offers insight into Aduhelm. Hosted on Acast. See acast.com/privacy for more information.

en

0:35

The BioWorld Insider Podcast - trailer

The BioWorld Insider Podcast ·

2021/06/04

Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. The BioWorld Insider podcast lets you hear directly from the movers and shakers whose collective work is changing how we all live. Join us each week for a new conversation. Hosted on Acast. See acast.com/privacy

en

53 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter